Biomotion Sciences Ordinary Shares Market Cap ($852.39K)
Market Cap & Net Worth: Biomotion Sciences Ordinary Shares (SLXN)
Biomotion Sciences Ordinary Shares market cap. Biomotion Sciences Ordinary Shares (NASDAQ:SLXN) has a market capitalization of $852.39K ($852.39K) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30778 globally and #6258 in its home market, demonstrating a -12.20% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biomotion Sciences Ordinary Shares's stock price $0.15 by its total outstanding shares 5560256 (5.56 Million). Also see SLXN cash flow conversion for how efficiently the company converts equity into cash flow.
Biomotion Sciences Ordinary Shares Market Cap History (2021–2026)
Biomotion Sciences Ordinary Shares market cap history from 2021 to 2026. Data shows change from $53.82 Million to $852.39K (-52.72% CAGR). Check Biomotion Sciences Ordinary Shares stock quote for real-time trading data and today's change.
Index Memberships
Biomotion Sciences Ordinary Shares is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #901 of 976 |
Weight: Biomotion Sciences Ordinary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Biomotion Sciences Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biomotion Sciences Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Biomotion Sciences Ordinary Shares (SLXN) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SLXN by Market Capitalization
Companies near Biomotion Sciences Ordinary Shares in the global market cap rankings as of November 4, 2026. Also see Biomotion Sciences Ordinary Shares assets under control for a full breakdown of the balance sheet.
Key companies related to Biomotion Sciences Ordinary Shares by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Biomotion Sciences Ordinary Shares (2021–2026)
Market capitalization of Biomotion Sciences Ordinary Shares from 2021 to today. Between 2021 and today, Biomotion Sciences Ordinary Shares's market cap moved from $53.82 Million to $ 852.39K, with a yearly change of -52.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $852.39K | -92.02% |
| 2025 | $10.68 Million | -4.48% |
| 2024 | $11.18 Million | -81.47% |
| 2023 | $60.33 Million | +7.75% |
| 2022 | $55.99 Million | +4.03% |
| 2021 | $53.82 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Biomotion Sciences Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $852.39K USD |
| MoneyControl | $852.39K USD |
| MarketWatch | $852.39K USD |
| marketcap.company | $852.39K USD |
| Reuters | $852.39K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Biomotion Sciences Ordinary Shares
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for … Read more